batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. BioNTech has some cancer convincing to do 20 March 2024 New Breyanzi approval comes at a timely moment for Allogene 18 March 2024 Takeda ploughs a lonely CD38 furrow 14 March 2024 Zynlonta gets squeezed 13 March 2024 Caribou joins Gilead and Astra in CLL-1 12 March 2024 Third pivotal trial for Moderna’s personalised immunotherapy 11 March 2024 Inhibrx breathes life into Ox40 8 March 2024 Zymeworks wakes up to the Enhertu threat 7 March 2024 Load More